These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26833165)

  • 1. Linezolid Surveillance Results for the United States (LEADER Surveillance Program 2014).
    Flamm RK; Mendes RE; Hogan PA; Streit JM; Ross JE; Jones RN
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2273-80. PubMed ID: 26833165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LEADER Program results for 2009: an activity and spectrum analysis of linezolid using 6,414 clinical isolates from 56 medical centers in the United States.
    Farrell DJ; Mendes RE; Ross JE; Sader HS; Jones RN
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3684-90. PubMed ID: 21670176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LEADER surveillance program results for 2010: an activity and spectrum analysis of linezolid using 6801 clinical isolates from the United States (61 medical centers).
    Flamm RK; Farrell DJ; Mendes RE; Ross JE; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2012 Sep; 74(1):54-61. PubMed ID: 22704791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008.
    Jones RN; Ross JE; Bell JM; Utsuki U; Fumiaki I; Kobayashi I; Turnidge JD
    Diagn Microbiol Infect Dis; 2009 Dec; 65(4):404-13. PubMed ID: 19913683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZAAPS Program results for 2015: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 32 countries.
    Pfaller MA; Mendes RE; Streit JM; Hogan PA; Flamm RK
    J Antimicrob Chemother; 2017 Nov; 72(11):3093-3099. PubMed ID: 28961701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An international activity and spectrum analysis of linezolid: ZAAPS Program results for 2011.
    Flamm RK; Mendes RE; Ross JE; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):206-13. PubMed ID: 23478031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linezolid surveillance program results for 2008 (LEADER Program for 2008).
    Farrell DJ; Mendes RE; Ross JE; Jones RN
    Diagn Microbiol Infect Dis; 2009 Dec; 65(4):392-403. PubMed ID: 19913682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of the surveillance of Tedizolid activity and resistance program: in vitro susceptibility of gram-positive pathogens collected in 2011 and 2012 from the United States and Europe.
    Sahm DF; Deane J; Bien PA; Locke JB; Zuill DE; Shaw KJ; Bartizal KF
    Diagn Microbiol Infect Dis; 2015 Feb; 81(2):112-8. PubMed ID: 25488274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers).
    Jones RN; Fritsche TR; Sader HS; Ross JE
    Diagn Microbiol Infect Dis; 2007 Nov; 59(3):309-17. PubMed ID: 17720350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms.
    Mendes RE; Deshpande LM; Jones RN
    Drug Resist Updat; 2014 Apr; 17(1-2):1-12. PubMed ID: 24880801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZAAPS Program results for 2010: an activity and spectrum analysis of linezolid using clinical isolates from 75 medical centres in 24 countries.
    Flamm RK; Farrell DJ; Mendes RE; Ross JE; Sader HS; Jones RN
    J Chemother; 2012 Dec; 24(6):328-37. PubMed ID: 23174097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daptomycin activity tested against linezolid-nonsusceptible gram-positive clinical isolates.
    Mendes RE; Jones RN; Deshpande LM; Ross JE; Sader HS
    Microb Drug Resist; 2009 Dec; 15(4):245-9. PubMed ID: 19857129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of a New cfr-Like Gene, cfr(B), in Enterococcus faecium Isolates Recovered from Human Specimens in the United States as Part of the SENTRY Antimicrobial Surveillance Program.
    Deshpande LM; Ashcraft DS; Kahn HP; Pankey G; Jones RN; Farrell DJ; Mendes RE
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6256-61. PubMed ID: 26248384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility trends including emergence of linezolid resistance among coagulase-negative staphylococci and meticillin-resistant Staphylococcus aureus from invasive infections.
    Decousser JW; Desroches M; Bourgeois-Nicolaos N; Potier J; Jehl F; Lina G; Cattoir V; Vandenesh F; Doucet-Populaire F;
    Int J Antimicrob Agents; 2015 Dec; 46(6):622-30. PubMed ID: 26453147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on linezolid in vitro activity through the Zyvox Annual Appraisal of Potency and Spectrum Program, 2013.
    Mendes RE; Hogan PA; Streit JM; Jones RN; Flamm RK
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2454-7. PubMed ID: 25645839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of linezolid as assessed through the 2013 LEADER surveillance program.
    Flamm RK; Mendes RE; Hogan PA; Ross JE; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2015 Apr; 81(4):283-9. PubMed ID: 25633420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. United States resistance surveillance results for linezolid (LEADER Program for 2007).
    Jones RN; Ross JE; Castanheira M; Mendes RE
    Diagn Microbiol Infect Dis; 2008 Dec; 62(4):416-26. PubMed ID: 19022153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of linezolid resistance in staphylococci and enterococci isolated from two teaching hospitals in Shanghai, China.
    Tian Y; Li T; Zhu Y; Wang B; Zou X; Li M
    BMC Microbiol; 2014 Nov; 14():292. PubMed ID: 25420718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of Linezolid Resistance Among Clinical
    Ruiz-Ripa L; Feßler AT; Hanke D; Eichhorn I; Azcona-Gutiérrez JM; Alonso CA; Pérez-Moreno MO; Aspiroz C; Bellés A; Schwarz S; Torres C
    Microb Drug Resist; 2021 Feb; 27(2):145-153. PubMed ID: 32456543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance for linezolid resistance via the Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) programme (2014): evolving resistance mechanisms with stable susceptibility rates.
    Mendes RE; Hogan PA; Jones RN; Sader HS; Flamm RK
    J Antimicrob Chemother; 2016 Jul; 71(7):1860-5. PubMed ID: 27013481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.